Previous studies found that LMNB1 was significantly upregulated in HCC and present in patient plasma, thus LMNB1 may be a potential diagnostic biomarker for detecting early-stage HCC patients [16,17]. This evidence concerns the gene LMNB1 and hepatocellular carcinoma.